ernie44
4 years ago
YUALLS DONT NEED CANUCKLEHEAD STUFF---AT ANY COST
AstraZeneca, which will supply up to 20 million doses of its viral vector vaccine candidate AZD1222.
Sanofi and GlaxoSmithKline, which will supply up to 72 million of doses of their protein subunit vaccine candidate.
Johnson & Johnson, which will supply up to 38 million doses of its viral vector vaccine candidate Ad26.COV2.S.
Novavax, which will supply up to 76 million doses of its protein subunit vaccine candidate NVX-CoV2373.
Pfizer, which will supply a minimum of 20 million doses of its mRNA vaccine candidate, BNT162. The government is negotiating with the company to expand the agreement to include options for obtaining additional doses.
Moderna, which will supply up to 56 million doseS
Steve1978
4 years ago
Copied from another board...
We had such an incredible afternoon today at MedMira Inc. Laboratory in #ClaytonParkWest!
#MedMira has come out with a patent for #COVID19 that can detect if you have antibodies within minutes, and will show the results for days to follow (which is something that is not common with these types of tests).
Just a few short months ago, 6 months to be exact, MedMira only had 11 staff members. Today, the company has expanded to 54 people! It was truly amazing to see all of their employees who come from over 18 countries; there are 6 summer students and over 30 new immigrants.
The expansion of staff is due to the high demand for their REVEALCOVID-19 TM Total Antibody test.
One of the most valuable things we noticed is that these individuals are extremely hard-working. This job is an exceptional way for them to get the Canadian working experience and to have flourishing and enriching careers!
We felt a true sense of family and community — this is the real beauty of Canada; There is opportunity and space for everyone to work in harmony.
The staff at MedMira contribute a weekly production of over 20,000 COVID-19 tests. We are told that the external performance evaluation of this product in the United States has been exceptional.
They also plan to expand to other markets, such as Europe and Asia.
Please stay tuned for a special feature from my office, highlighting a behind-the-scenes look at MedMira Inc.
Thank you to Hermes Chan (CEO) and Markus Meile (CFO), for your information breakdown of the antibody test. As well as all the exciting things your company is doing and plans to do in the future.
We wish you the best of luck!
ernie44
4 years ago
Trial enrollment is definitely slowing. Only 2,000 people added this week:
https://www.modernatx.com/cove-study
6500 left until enrollment complete :) 3 weeks/month left? -- MRNA
Nine vaccine developers made a socially positive pledge Tuesday to follow scientific and ethical standards in their development of Covid-19 vaccines, and not to push for rapid regulatory approval or authorization. The pledge, meant to ensure public confidence in the scientific and regulatory process, comes amid growing scepticism of a hastened Covid-19 vaccine. A YouGov poll on September 3 showed that only 42% of Americans would get vaccinated against Covid-19, while 27% said they would not, leaving 31% still uncertain. Three other signatories, Pfizer, BioNTech, and Moderna also have vaccines in phase 3 clinical trials.